|
Effects of Bright-light Exposure Combined With Specific Exercise Training (BEST) Program in Patients With Cancer
RECRUITINGN/ASponsored by Taipei Veterans General Hospital, Taiwan
Actively Recruiting
PhaseN/A
SponsorTaipei Veterans General Hospital, Taiwan
Started2023-07-24
Est. completion2028-05-15
Eligibility
Age20 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT05875870
Summary
This study plans to investigate the effectiveness of six-week light exposure combined with an exercise training program on improving sleep-wake rhythm, physical and mental symptoms, quality of life, one-year recurrence rate, and one-year survival rate of patients with lung and esophageal cancer.
Eligibility
Age: 20 Years+Healthy volunteers accepted
Inclusion Criteria: 1. Patients with newly diagnosed primary lung cancer or esophageal cancer, from the first stage to the third stage. 2. At least 20 years of age. 3. Able to communicate in Mandarin Chinese or Taiwanese. 4. Literate and free from cognitive disabilities. 5. The attending physician agrees to participate in the study. 6. Those who can connect to the Internet with mobile devices such as computers, mobile phones, and tablets, or those whose family members can assist in the operation. 7. Those with Karnofsky Performance Scale (KPS) greater than or equal to 70 points. 8. Those who are hospitalized for lung cancer or esophageal cancer lesion resection. Exclusion Criteria: 1. Congestive heart failure. 2. Orthopedic diseases of the lower extremities that limit one's walking ability.
Conditions4
CancerEsophageal NeoplasmsLung CancerLung Neoplasm
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorTaipei Veterans General Hospital, Taiwan
Started2023-07-24
Est. completion2028-05-15
Eligibility
Age20 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT05875870